Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum pepsinogen and gastric cancer screening.
Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, Ichinose M. Mukoubayashi C, et al. Among authors: oka m. Intern Med. 2007;46(6):261-6. doi: 10.2169/internalmedicine.46.6181. Epub 2007 Mar 15. Intern Med. 2007. PMID: 17379991 Free article. Review.
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K, Ohata H, Fujishiro M, Takeshita T, Mohara O, Ichinose M. Yanaoka K, et al. Among authors: oka m. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):838-45. doi: 10.1158/1055-9965.EPI-07-2762. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18398025 Clinical Trial.
Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
Yanaoka K, Oka M, Yoshimura N, Mukoubayashi C, Enomoto S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K, Yamamichi N, Fujishiro M, Takeshita T, Mohara O, Ichinose M. Yanaoka K, et al. Among authors: oka m. Int J Cancer. 2008 Aug 15;123(4):917-26. doi: 10.1002/ijc.23571. Int J Cancer. 2008. PMID: 18508314 Free article.
Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Inoue I, Iguchi M, Maekita T, Ueda K, Utsunomiya H, Tamai H, Fujishiro M, Iwane M, Takeshita T, Mohara O, Ichinose M. Yanaoka K, et al. Among authors: oka m. Int J Cancer. 2009 Dec 1;125(11):2697-703. doi: 10.1002/ijc.24591. Int J Cancer. 2009. PMID: 19610064 Free article.
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M. Yoshida T, et al. Among authors: oka m. Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3. Int J Cancer. 2014. PMID: 24009139 Free article.
Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography.
Ohata H, Oka M, Yanaoka K, Shimizu Y, Mukoubayashi C, Mugitani K, Iwane M, Nakamura H, Tamai H, Arii K, Nakata H, Yoshimura N, Takeshita T, Miki K, Mohara O, Ichinose M. Ohata H, et al. Among authors: oka m. Cancer Sci. 2005 Oct;96(10):713-20. doi: 10.1111/j.1349-7006.2005.00098.x. Cancer Sci. 2005. PMID: 16232204 Free article. Clinical Trial.
Multifocal nodular fatty infiltration of the liver mimicking metastatic liver tumors: diagnosis using the liver-specific late phase of Levovist-enhanced sonography.
Tamai H, Shingaki N, Oka M, Shiraki T, Inoue I, Magari H, Fujishiro M, Iguchi M, Yanaoka K, Arii K, Shimizu Y, Ichinose M. Tamai H, et al. Among authors: oka m. J Ultrasound Med. 2006 Mar;25(3):403-6. doi: 10.7863/jum.2006.25.3.403. J Ultrasound Med. 2006. PMID: 16495505 No abstract available.
Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level.
Enomoto S, Tamai H, Oka M, Shingaki N, Shiraki T, Takeuchi M, Deguchi H, Magari H, Inoue I, Iguchi M, Yanaoka K, Arii K, Fujishiro M, Yahagi N, Yotsuyanagi H, Ichinose M. Enomoto S, et al. Among authors: oka m. Hepatol Res. 2007 Sep;37(9):692-700. doi: 10.1111/j.1872-034X.2007.00112.x. Epub 2007 Jun 15. Hepatol Res. 2007. PMID: 17573949
2,296 results